Prosecution Insights
Prosecution Insights
30 pending office actions • 17 clients • 28 examiners • 23 art units • 0 of 30 (0%) have an AI response strategy ready • 36 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 18 (60%) |
| §102 only | 3 (10%) |
| §112 only | 3 (10%) |
| Double-patenting only | 4 (13%) |
| No statute on record | 2 (7%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CARPENTER, WILLIAM R | 2 | 54.3% | +52.8% |
| SPENCE, JENNIFER SUZANNE | 2 | 65.3% | +50.3% |
| ADEBOYEJO, IFEOLU A | 1 | 47.9% | +43.8% |
| TRAN, JULIA C | 1 | 62.6% | +27.9% |
| SABOURI, MAZDA | 1 | 77.2% | +16.8% |
| FURTADO, WINSTON RAHUL | 1 | 19.2% | +25.0% |
| GIBBS, TERRA C | 1 | 63.8% | +10.5% |
| HADEN, SALLY CLINE | 1 | 32.0% | +40.8% |
| BAILEY, AMANDA LEE | 1 | 55.4% | +43.0% |
| WEYDEMEYER, ETHAN | 1 | 43.7% | +44.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18738564 | PERSONALIZED INSIGHTS INTO TUMOR EVOLUTION AND AI-BASED TREATMENT DECISION SUPPORT SYSTEMS AND METHODS | FURTADO, WINSTON RAHUL | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18446401 | AUTO-INJECTION DEVICE | CARPENTER, WILLIAM R | 52d overdue |
| 18522001 | AUTO-INJECTION DEVICE | CARPENTER, WILLIAM R | 36d overdue |
| 17757069 | MODIFIED CELLS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SPENCE, JENNIFER SUZANNE | 30d overdue |
| 16927304 | TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER | SPENCE, JENNIFER SUZANNE | 30d overdue |
| 18750401 | MOBILITY ENFORCEMENT IN CONNECTED WIRELESS STATE | SABOURI, MAZDA | 6d |
| 18738564 | PERSONALIZED INSIGHTS INTO TUMOR EVOLUTION AND AI-BASED TREATMENT DECISION SUPPORT SYSTEMS AND METHODS | FURTADO, WINSTON RAHUL | 21d |
| 18653869 | COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY | GIBBS, TERRA C | 29d |
| 19038875 | SPRING MODULE AND SPRING CUSHION FOR FURNITURE | ADEBOYEJO, IFEOLU A | — |
| Art Unit | Apps |
|---|---|
| 1635 | 3 |
| 3783 | 3 |
| 1674 | 2 |
| 1633 | 2 |
| 3679 | 1 |
| 2641 | 1 |
| 3687 | 1 |
| 3732 | 1 |
| 3673 | 1 |
| 1783 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19038875 | SPRING MODULE AND SPRING CUSHION FOR FURNITURE | New-Tec Integration (Xiamen) Co., Ltd. | ADEBOYEJO, IFEOLU A | 3679 | §103 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18823633 | DUAL-DIRECTION TILLER/CULTIVATOR | Ardisam, Inc. | TRAN, JULIA C | §103 | Non-Final OA | — | Pending | Sep 03, 2024 | |
| 18750401 | MOBILITY ENFORCEMENT IN CONNECTED WIRELESS STATE | ZTE CORPORATION | SABOURI, MAZDA | 2641 | §103 | Final Rejection | 6d | Pending | Jun 21, 2024 |
| 18738564 | PERSONALIZED INSIGHTS INTO TUMOR EVOLUTION AND AI-BASED TREATMENT DECISION SUPPORT SYSTEMS AND METHODS | UNIVERSITY OF WASHINGTON | FURTADO, WINSTON RAHUL | 3687 | §103 | Final Rejection | 21d | Pending | Jun 10, 2024 |
| 18653869 | COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY | City Of Hope | GIBBS, TERRA C | 1635 | §103 | Non-Final OA | 29d | Pending | May 02, 2024 |
| 18648238 | GLOVE WITH STRUCTURAL FINGER REINFORCEMENTS | Rawlings Sporting Goods Company, Inc. | HADEN, SALLY CLINE | 3732 | §102 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18687729 | ELASTIC CUSHION AND FURNITURE | New -Tec Integration (Xiamen) Co., Ltd. | BAILEY, AMANDA LEE | 3673 | §103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18682846 | ELASTIC MODULE BALANCE CUSHION, ELASTIC CUSHION, AND FURNITURE | New-Tec Integration (Xiamen) Co., Ltd. | WEYDEMEYER, ETHAN | 1783 | §102 | Final Rejection | — | Pending | Feb 09, 2024 |
| 18537590 | DEVICE FOR STORING AND VAPORIZING LIQUID MEDIA | Fontem Ventures B.V. | BURGOS-GUNTIN, NELSON R | 2831 | §103 | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18529891 | VARIABLE-VOLUME CONE FOR RESTRAINING BIRDS | Ardisam, Inc. | ALMATRAHI, SAHAR FARIS | 3643 | §103 | Final Rejection | — | Pending | Dec 05, 2023 |
| 18522001 | AUTO-INJECTION DEVICE | Shl Medical AG | CARPENTER, WILLIAM R | 3783 | §112 | Final Rejection | 36d overdue | Pending | Nov 28, 2023 |
| 18557406 | MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF | Fred Hutchinson Cancer Center | CORNELIUS, CLAIRE ADRIENNE | 1672 | §103 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18554286 | CANCER TREATMENT BY TARGETING PROTEINS OR INTERACTIONS OF EPHRINB-RGS3-KIF20A-SEPT7 AXIS | City Of Hope | MEYERING, SHABANA SHABBEER | 1635 | §103 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18452732 | CHARGING CASE FOR ELECTRONIC SMOKING DEVICE | Fontem Holdings 1 B.V. | TRISCHLER, JOHN T | 2859 | §103 | Final Rejection | 24d overdue | Pending | Aug 21, 2023 |
| 18447570 | CAMERA CRANE | Chapman/Leonard Studio Equipment, Inc. | CHANG, FANG-CHI | 2852 | §103 | Final Rejection | 43d overdue | Pending | Aug 10, 2023 |
| 18446401 | AUTO-INJECTION DEVICE | Shl Medical AG | CARPENTER, WILLIAM R | 3783 | §102 | Final Rejection | 52d overdue | Pending | Aug 08, 2023 |
| 18360744 | ELECTROMECHANICAL INGESTIBLE DEVICE FOR DELIVERY OF A DISPENSABLE SUBSTANCE | BIORA THERAPEUTICS, INC. | BRANDT, DAVID NELSON | 3783 | §103 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18353767 | ELECTRONIC CIGARETTE WITH ILLUMINATED TIP | Fontem Ventures B.V. | YAARY, ERIC | 1755 | §103 | Non-Final OA | 49d overdue | Pending | Jul 17, 2023 |
| 18270706 | PREVENTION AND TREATMENT OF STEROID-RESISTANT OR GUT GRAFT-VERSUS-HOST DISEASE (GVHD) | Ciy Of Hope | FORD, VANESSA L | 1674 | §112 | Non-Final OA | 40d | Pending | Jun 30, 2023 |
| 18251871 | THERAPEUTIC TARGETING OF MESOTHELIN IN ACUTE MYELOID LEUKEMIA WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY | Fred Hutchinson Cancer Center | HOWARD, ZACHARY C | 1674 | §103 | Final Rejection | — | Pending | May 04, 2023 |
| 17999352 | ENGINEERED ANTI-PROSTATE STEM CELL ANTIGEN FUSION PROTEINS AND USES THEREOF | The Regents of the University of California | CUNNINGCHEN, KATHLEEN MARY | 1646 | DP | Final Rejection | 88d overdue | Pending | Nov 18, 2022 |
| 17998011 | METHODS FOR ORGANOIDS PRODUCTION | City Of Hope | LEPAGE, JONATHAN EVERETT | 1796 | §103 | Final Rejection | — | Pending | Nov 04, 2022 |
| 17932239 | SYNTHETIC MODIFIED VACCINIA ANKARA (sMVA) BASED CORONAVIRUS VACCINES | City Of Hope | QIAN, CELINE X | 1637 | DP | Final Rejection | 217d overdue | Pending | Sep 14, 2022 |
| 17757069 | MODIFIED CELLS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | Editas Medicine, Inc. | SPENCE, JENNIFER SUZANNE | 1633 | Other | Final Rejection | 30d overdue | Pending | Jun 08, 2022 |
| 17533007 | EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES | Editas Medicine, Inc. | LEITH, NANCY J | 1636 | §103 | Final Rejection | 28d | Pending | Nov 22, 2021 |
| 17433975 | CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP) | Editas Medicine, Inc. | SULLIVAN, STEPHANIE LAUREN | 1635 | DP | Final Rejection | 114d overdue | Pending | Aug 25, 2021 |
| 17015500 | GLP-1 COMPOSITION FOR TREATING OBESITY AND WEIGHT MANAGEMENT | Shanghai Benemae Pharmaceutical Corporation | SABILA, MERCY HELLEN | 1654 | DP | Non-Final OA | 73d overdue | Pending | Sep 09, 2020 |
| 16968504 | PROMOTING AND PROTECTING FUNCTIONAL BETA CELL MASS BY SYNTAXIN 4 ENRICHMENT | City Of Hope | CONNORS, ALEXANDRA F | 1634 | §112 | Non-Final OA | — | Pending | Aug 07, 2020 |
| 16927304 | TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER | UNIVERSITY OF ALABAMA AT BIRMINGHAM | SPENCE, JENNIFER SUZANNE | 1633 | Other | Non-Final OA | 30d overdue | Pending | Jul 13, 2020 |
| 15045068 | STABLE AQUEOUS PARENTERAL PHARMACEUTICAL COMPOSITIONS OF INSULINOTROPIC PEPTIDES | Shanghai Benemae Pharmaceutical Corporation | KOMATSU, LI N | 1658 | §103 | Final Rejection | 86d overdue | Pending | Feb 16, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial